The Emergence of Retailing of Generic Medicines: An Awareness Study at Kakinada, Andhra Pradesh

Authors

  •   Kuberudu Burlakanti Professor and Head, Department of Management Studies, Andhra University Campus, Kakinada - 533 005, East Godavari District, Andhra Pradesh
  •   Romala Vijaya Srinivas Assistant Professor, Department of Management Studies, Aditya P.G. College, Kakinada, East Godavari District, Andhra Pradesh

DOI:

https://doi.org/10.17010/ijom/2013/v43/i12/80510

Keywords:

Generic Medicines

, Consumers' Awareness, Retailing, Availability, Demographics

Paper Submission Date

, April 16, 2013, Paper sent back for Revision, August 20, Paper Acceptance Date, October 1, 2013.

Abstract

Using lower price generic medicines for chronic diseases provides efficacy similar to branded medicines. However, previous studies showed that disadvantaged people, who may particularly benefit from cost savings, have low trust on generics and showed increased reluctance to switch to generics. The rural areas include areas of high poverty and minority communities whose members are at high risk for poor health outcomes. However, whether such beliefs exist in these communities has not been reported. We sought to obtain qualitative insights about awareness and usage of generic medication among the people in urban and rural areas of Kakinada city. This survey showed that there is a gap in consumers' awareness and availability of generic medicines in urban and rural areas of Kakinada. The findings of the study suggest that awareness needs to be spread among the customers about generic medicines. Besides, it is an emerging business opportunity for local medical retailers.

Downloads

Download data is not yet available.

Downloads

Published

2013-12-01

How to Cite

Burlakanti, K., & Srinivas, R. V. (2013). The Emergence of Retailing of Generic Medicines: An Awareness Study at Kakinada, Andhra Pradesh. Indian Journal of Marketing, 43(12), 12–23. https://doi.org/10.17010/ijom/2013/v43/i12/80510

References

Abbott, F.M. (2013, April 04). Inside views: The judgment in Novartis v. India: What the Supreme Court of India said. Intellectual Property Watch. Retrieved from http://www.ip-watch.org/2013/04/04/the-judgment-in-novartis-v-india-what-the-supreme-court-of-india-said/

Aiyar, S.A. (2013). West should learn from India's high patent standards. Retrieved from http://www.scribd.com/doc/153150555/Swaminathan-Aiyar-Article-on-7th-April-West-Should-Learn-From-India

Babar, Z.U., Stewart, J., Reddy, S., Alzaher, W., Vareed, P., Yacoub, N. .... & Rew, A. (2010). An evaluation of consumers' knowledge, perceptions and attitudes regarding generic medicines in Auckland. Pharm World Science Journal, 32(4), 440-448. DOI: 10.1007/s11096-010-9402-0.

Banka, N. (2013). The critical analysis of Novartis v. Cipla case verdict by Supreme Court [web log post]. Retrieved from http://legalconnectindia.blogspot.in/2013/04/the-critical-analysis-of-novartis-v.html

Basheer, S. (2005). India's tryst with TRIPS: The Patents (Amendment) Act, 2005. The Indian Journal of Law and Technology, 1(1), 15-46. Retrieved from http://www1.nls.ac.in/ojs-2.2.3/index.php/IJLT/article/viewFile/7/5

Bennett, D. E., Bertagnolio, S., Sutherland, D., & Gilks, C.F. (2008). The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antiviral Therapy, 13(2), 1-13. Retrieved from http://www.who.int/hiv/drugresistance/WHO_HIVDR_strategy.pdf

Gaither, C.A., Kirking, D.M., Ascione, F.J., & Welage, L.S. (2001). Consumers' views on generic medications. Journal of American Pharmacists Association, 41 (5), 729-736.

Grover, A. (2013, April 02). Novartis case: Supreme Court's historic decision on Section 3(d). The Times of India. Retrieved from http://articles.timesofindia.indiatimes.com/2013-04-02/india/38217259_1_therapeutic-efficacy-chennai-patent-office-patent-oppositions

Generic drug. (n.d.). In Wikipedia. Retrieved August 16, 2013, from http://en.wikipedia.org/wiki/Generic_drug

Gill, L., Helkkula, A., Cobelli, N., & White, L. (2010). How do customers and pharmacists experience generic substitution? International Journal of Prognostics and Health Management, 4 (4), 375-395.

Hannon, E. (2012, August 21). How an Indian patent case could shape the future of generic drugs. Time World. Retrieved from http://world.time.com/2012/08/21/how-an-indian-patent-case-could-shape-the-future-of-generic-drugs/#ixzz2E3oygauR

Haskins, L.S., Tomaszewski, K.J., & Crawford, P. (2005). Patient and physician reactions to generic antiepileptic substitution in the treatment of epilepsy. Epilepsy& Behaviour, 7 (1), 98-105.

Himmel, W., Simmenroth Nayda, A., Niebling, W., Ledig, T., Jansen, R.D, Kochen, M.M., Gleiter, C.H., Hummers-Pradier, E. (2005).What do primary care patients think about generic drugs? International Journal of Clinical Pharmacology Therapeutics, 43 (10), 472-479.

Kakinada. (n.d.). In Wikipedia. Retrieved August 16, 2013, from http://en.wikipedia.org/wiki/Kakinada

Kjoenniksen I., Lindbaek M., & Granas, A. G. (2006). Patients' attitudes towards and experiences of generic drug substitution in Norway. Pharmacy World and Science, 28 (5), 284-289.

Love, J. (2011). The production of generic drugs in India. BMJ, 342. DOI: http://dx.doi.org/10.1136/bmj

Mohanta, G.P., Jana, U., & Manna, P.K. (2012, December 19). Promoting generic medicines. Pharmabiz.com. Retrieved from http://www.pharmabiz.com/ArticleDetails.aspx?aid=72777&sid=9

Nair, G.G. (2008). Impact of TRIPS on Indian pharmaceutical industry. Journal of Intellectual Property Rights, 13 (9), 432-441.

Novartis v. Union of India & Others. (n.d.). In Wikipedia. Retrieved August 16, 2013, from http://en.wikipedia.org/wiki/Novartis_v._Union_of_India_%26_Others

Palagyi M., & Lassanova M. (2008). Patients attitudes towards experience with use of generics in Slovakia, performance of generic substitution. Bratisl Lek Listy, 109 (7), 324-328.

Roman,B. (2009). Patients' attitudes towards generic substitution of oral atypical antipsychotics: A questionnaire-based survey in a hypothetical pharmacy setting. CNS Drugs, 23 (8), 693-701. DOI: 10.2165/00023210-200923080-00006

Shrank, W.H., Cox, E.R., Fischer, M.A., Mehta, J., & Choudhry, N.K. (2009). Patients' perceptions of generic medications. Health Aff (Millwood), 28 (2), 546-556. DOI: 10.1377/hlthaff.28.2.546.

Supreme Court's decision on Novartis to benefit poor patients: Pharma companies. (2013, April 1). The Economic Times. Retrieved from http://articles.economictimes.indiatimes.com/2013-04-01/news/38189629_1_poor-patients-judgement-glivec

Supreme Court to pass landmark judgement on Novartis pharma patents case today. (2013, April 01). India Today. Retrieved from http://indiatoday.intoday.in/story/novartis-patent-case-supreme-court-judgement/1/260082.html

Vallès J. A. et al. (2003). A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy, 65 (3), 269-275.